The post Abercrombie & Fitch Goes Western With Kemo Sabe Brand Collaboration appeared on BitcoinEthereumNews.com. Models wearing the new A & F X Kemo Sabe collection. Photo Courtesy of Abercrombie & Fitch While the brand collaboration can be traced back to 1924 when Château Mouton Rothschild commissioned Jean Carlu to design a wine bottle label, the modern-day collaboration which merged when Nike teamed up with Commes Des Garcons, hit a pivotal moment when H&M released its first designer collaboration with Karl Lagerfeld. Since then, the mutual benefit that mass audience brands and specialty luxury brands can garner from one another is undeniable. Such is the case with a new partnership between Abercrombie & Fitch and Kemo Sabe, the cult-status luxury Western-centric accessories and outwear store that was founded in Aspen, CO. in 1990. The offering Abercrombie X Kemo Sabe offering, which features twelve women’s clothing styles and three accessories’ styles will launch October 30th on online at Abercrombie.com and all stores globally November 6th. The collection debuted in Manhattan a few weeks in advance to press at a presentation held at Common Country bar where Corey Robinson, chief product officer of Abercrombie & Fitch Co. and Wendy Kunkle, President and Owner of Kemo Sabe were on hand to discuss the unique pair up. A model wears a dress from the A & F X Kemo Sabe collection. Photo courtesy of Abercrombie & Fitch According to Robinson, the partnership had organic beginnings. “A few summers ago, my family and I visited Kemo Sabe on vacation in Aspen. I’d been a fan for a few years. I was buying turquoise bracelet, and I met Wendy and our energy just clicked. She made my husband a hat and the kids got them too,” Robinson recalled. Shortly after Abercrombie & Fitch Co. CEO Fran Horowitz had visited the Park City, UT. “She immediately texted me to ask if I… The post Abercrombie & Fitch Goes Western With Kemo Sabe Brand Collaboration appeared on BitcoinEthereumNews.com. Models wearing the new A & F X Kemo Sabe collection. Photo Courtesy of Abercrombie & Fitch While the brand collaboration can be traced back to 1924 when Château Mouton Rothschild commissioned Jean Carlu to design a wine bottle label, the modern-day collaboration which merged when Nike teamed up with Commes Des Garcons, hit a pivotal moment when H&M released its first designer collaboration with Karl Lagerfeld. Since then, the mutual benefit that mass audience brands and specialty luxury brands can garner from one another is undeniable. Such is the case with a new partnership between Abercrombie & Fitch and Kemo Sabe, the cult-status luxury Western-centric accessories and outwear store that was founded in Aspen, CO. in 1990. The offering Abercrombie X Kemo Sabe offering, which features twelve women’s clothing styles and three accessories’ styles will launch October 30th on online at Abercrombie.com and all stores globally November 6th. The collection debuted in Manhattan a few weeks in advance to press at a presentation held at Common Country bar where Corey Robinson, chief product officer of Abercrombie & Fitch Co. and Wendy Kunkle, President and Owner of Kemo Sabe were on hand to discuss the unique pair up. A model wears a dress from the A & F X Kemo Sabe collection. Photo courtesy of Abercrombie & Fitch According to Robinson, the partnership had organic beginnings. “A few summers ago, my family and I visited Kemo Sabe on vacation in Aspen. I’d been a fan for a few years. I was buying turquoise bracelet, and I met Wendy and our energy just clicked. She made my husband a hat and the kids got them too,” Robinson recalled. Shortly after Abercrombie & Fitch Co. CEO Fran Horowitz had visited the Park City, UT. “She immediately texted me to ask if I…

Abercrombie & Fitch Goes Western With Kemo Sabe Brand Collaboration

Models wearing the new A & F X Kemo Sabe collection.

Photo Courtesy of Abercrombie & Fitch

While the brand collaboration can be traced back to 1924 when Château Mouton Rothschild commissioned Jean Carlu to design a wine bottle label, the modern-day collaboration which merged when Nike teamed up with Commes Des Garcons, hit a pivotal moment when H&M released its first designer collaboration with Karl Lagerfeld. Since then, the mutual benefit that mass audience brands and specialty luxury brands can garner from one another is undeniable.

Such is the case with a new partnership between Abercrombie & Fitch and Kemo Sabe, the cult-status luxury Western-centric accessories and outwear store that was founded in Aspen, CO. in 1990. The offering Abercrombie X Kemo Sabe offering, which features twelve women’s clothing styles and three accessories’ styles will launch October 30th on online at Abercrombie.com and all stores globally November 6th. The collection debuted in Manhattan a few weeks in advance to press at a presentation held at Common Country bar where Corey Robinson, chief product officer of Abercrombie & Fitch Co. and Wendy Kunkle, President and Owner of Kemo Sabe were on hand to discuss the unique pair up.

A model wears a dress from the A & F X Kemo Sabe collection.

Photo courtesy of Abercrombie & Fitch

According to Robinson, the partnership had organic beginnings. “A few summers ago, my family and I visited Kemo Sabe on vacation in Aspen. I’d been a fan for a few years. I was buying turquoise bracelet, and I met Wendy and our energy just clicked. She made my husband a hat and the kids got them too,” Robinson recalled.

Shortly after Abercrombie & Fitch Co. CEO Fran Horowitz had visited the Park City, UT. “She immediately texted me to ask if I knew the brand to which I replied, ‘I love it and know the owner,’” Robinson continued. The CEO agreed and the partnership was formalized in March.

“We have not done a true collaboration with a brand in a very, very, very long time. So, we’re going to be thoughtful about who we do this with, since this is not something we do often,” Robinson explained.

“Our customers are in 20s/30s, and they love Kemo Sabe and it has become a destination to buy a hat. Others will discover Kemo Sabe, a luxury brand, at relatively accessible price points,” Robinson said.

That said, for A&F it’s an elevated range with the limited-edition collection ranging from $50 to $500 for a natural leather jacket. It will be limited-edition and in select stores

A leather jacket from the A & F X Kemo Sabe collaboration.

Photo courtesy of Abercrombie & Fitch

“Typically, we offer vegan leather, and this is the first true leather jacket we have done in a while. It’s a higher price point for the A&F customer but still attainable,” Robinson noted. While A & F is known common as a ‘fleece’ brand some of the other best-sellers in the brand are dresses and denim which the collection offers. The latter will be available in both classic and Curve love cuts and product details such as authentic-finish studding, traditional ‘bug and wrinkle’ inspired stitching and embroidery. Though in just the right amount.

“I am not a big fan of too much embroidery. I want to have that dress for the rest of my life in my closet. I don’t want it to be out of style next year,” said Kurkle. The partnership marks the brand’s first global retail project.

With Kemo Sabe, A&F formed a true working partnership to create the product and the identity, working hand in hand to create what made sense. “What I’ve loved about working with Wendy is that she had a strong point of view from the beginning. There were some things where she was like, ‘Nope, we’re not doing that. It’s better work with a partner that has such a strong point of view is actually as a brand, it feels more authentic with having the handwriting of both brands on it,”

A model wear pieces of the A & F X Kemo Sabe collaboration collection.

Photo courtesy of Abercrombie & Fitch

“We’re high-end luxury western store, but when I say western, that’s a tricky word. Our brand aesthetic is fashion western than cowboy-inspired wear,” Kurkle continued. The Kemo Sabe customer is usually based in places such as Chicago, New York and Dallas ‘where they don’t actually dress in typical western styles.’ Her stores are located in Aspen, Vail, Park City, Utah, Round Top, Texas and Jackson Hole and Whitefish, both in Montana. In 2024 the brand did a pop up in New York City.

“We want this style to be accessible to people that wouldn’t normally wear it in the city, but now they do because we’ve introduced a higher-end version of Western that’s wearable, timeless and super classic,” she added noting that the Kemo Sabe customer is now looking at Abercrombie & Fitch for the first time in a while.

According to Robinson the collection will be in key locations such as Flatiron and Greenwich Avenue in New York and Lincoln Park in Chicago, Newbury Street in Boston, Westfield Century City in LA and Oxford Street in London. Robinson noted that the brand has moved away from the flagship prestige real estate strategy and meets the customer where they are at.

Western belt included in the A & F X Kemo Sabe collaboration.

Photos courtesy of Abercrombie & Fitch

Kurkle was drawn to the brand’s 130-year -old legacy. “That Abercrombie is American owned was unbelievable to me. Our factories are all in the states as well, and I just loved that heritage about them. I loved the people on their team and it’s a woman-led company. They used to be a hunting store and we’re from the West,” Kurkle enthused.

They also have another big thing in common. Each is infamous for having lines out the door. Kurkle lays it out this way. “We create a shopping experience that is pure joy at Kemo Sabe. Our goal is everybody should feel excitement when they come into our store. We serve free drinks; you can relax and meet amazing people. It’s crammed with people, dancing and yelling and it’s a lot of fun. We have lines out the door, people can wait 45 minutes to get in.”

Or they can hit up A&F for their next Kemo Sabe staples.

Source: https://www.forbes.com/sites/roxannerobinson/2025/10/30/abercrombie–fitch-goes-western-with-kemo-sabe-brand-collaboration/

Market Opportunity
SynFutures Logo
SynFutures Price(F)
$0.006684
$0.006684$0.006684
-1.51%
USD
SynFutures (F) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23